Hydrocortisone Acetate Suppository shortage

Not a nationwide shortage — Padagis US has told the FDA it is discontinuing its hydrocortisone acetate suppositories.

  • The FDA lists this under “To be discontinued” as of Nov 22, 2026: a company stopping its own product.
  • 16 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
Status
FDA term: “To Be Discontinued”
Products on the record
2
Category
First posted
Jul 23, 2026
Last updated
Jul 23, 2026

This page is curated, coded, and maintained by ⁠ Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy

Source: FDA Drug Shortages Database API (openFDA). Last refreshed Nov 22, 2026 (today).

The Bottom Line

Padagis is stopping its hydrocortisone acetate suppositories, and this change may be permanent. The same medicine is still listed in 25 mg and 30 mg strengths by other makers that have not reported a shortage.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Is Hydrocortisone Acetate Being Discontinued? Status as of Nov 22, 2026

Not as a whole, as of Nov 22, 2026. Padagis US is stopping its own version only; 16 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.

Supply Risk: Low

0 of 5 risk factors

Your pharmacy can often still get it, though it may need to be ordered. It is our estimate across the country, not a check of your pharmacy’s shelves.

Which of the Five Risk Factors Apply

  • A strength with no makerAll 2 strengths on the record are still made by a company. Does not apply
  • Down to one company16 companies may still have it: the one company that reported the shortage reports no supply, and 16 more have not reported a problem. Does not apply
  • Most products unavailableThe FDA’s list gives no count, but at least one company may still have it. Does not apply
  • Over three monthsThis is a discontinuation notice, which does not count as an outage. Does not apply
  • Few companies make it17 companies make it: 1 that reported the shortage and 16 that have not. Does not apply

What each rating means ↓

The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.

Availability of the Affected Products

From the FDA shortage report: 2 products

  • 2

Is Every Strength Still Made?

A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.

2 of 2 strengths

  • 25 mgStill made by a company
  • 30 mgStill made by a company

Other Companies Listing the Same Medicine, Not Reporting a Shortage

Companies that list Hydrocortisone Acetate Suppository with the FDA and have not reported a shortage (not counted in the charts above).

  • Cosette Pharmaceuticals, Inc.
  • Major Pharmaceuticals
  • Marlex Pharmaceuticals, Inc.
  • Laser Pharmaceuticals, LLC
  • Rising Pharma Holdings, Inc.
  • APNAR PHARMA LP
  • Patrin Pharma Inc.
  • A-S Medication Solutions
  • AvPAK
  • Golden State Medical Supply, Inc.
  • Bryant Ranch Prepack
  • Salix Pharmaceuticals, Inc
  • Westminster Pharmaceuticals, LLC
  • Proficient Rx LP
  • Nivagen Pharmaceuticals, Inc.
  • AARNA USA INC.

Plus 9 other dosage forms of hydrocortisone acetate.

See all other options & details ↓

Shortage Timeline

  1. Jul 23, 2026 Discontinuation notice on file 2 of 2 products affected.
  2. Jul 23, 2026 First reported to the FDA 2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

Which Hydrocortisone Acetate Products Are Affected, by Company

Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get hydrocortisone acetate?).

Company: Padagis US LLC 2 products · (800) 775-2054
  • Hydrocortisone Acetate Suppository, 30 mg

    00574-7093-12
    Strength
    30 mg
    Availability
    Not stated

    Notes: Discontinuation of the manufacture of the drug

  • Hydrocortisone Acetate Suppository, 25 mg

    00574-7090-12
    Strength
    25 mg
    Availability
    Not stated

    Notes: Discontinuation of the manufacture of the drug

Why Is Padagis US Discontinuing Hydrocortisone Acetate?

A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026

I looked at what the FDA has on file for this one, and it's pretty simple. Padagis US LLC has reported that it is discontinuing the manufacture of its hydrocortisone acetate suppositories. That means the company is choosing to stop making them, rather than running into a temporary problem like a factory hold-up.

This applies to two products from Padagis: the 25 mg suppository (NDC 0574-7090-12) and the 30 mg suppository (NDC 0574-7093-12). The FDA did not list a specific reason code, and the manufacturer's notes only say "discontinuation of the manufacture of the drug," so there is no public explanation for why. No dates were shared, and no strength or package size was identified as continuing. This report covers only Padagis and these two products.

What Should I Do If I Take Hydrocortisone Acetate?

A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026

Hydrocortisone acetate suppositories are currently on the FDA drug shortage list, but the overall supply risk is rated low (1 of 5). The shortage report comes from one company, Padagis US LLC, which is discontinuing its 25 mg and 30 mg suppositories. Neither strength has a source from Padagis right now. Both the 25 mg and 30 mg strengths are still listed by other companies that did not report a shortage.

The reported reason is that Padagis has stopped making this product. Because it is marked "to be discontinued," supply from Padagis may not return. This affects only that one maker. Several other companies, including Cosette, Major, Marlex, Laser, Rising, APNAR, Patrin and A-S Medication Solutions, list the same medicine in 25 mg and/or 30 mg.

What you can do:

  1. Do not stop, skip, or change how you use this medicine on your own.
  2. Ask your pharmacy to order the same medicine from another maker in your strength. They can check wholesalers, though it may not be in local stock right away.
  3. If your strength cannot be found, talk with your prescriber or pharmacist about options. A clinician should choose any alternative.
  4. Padagis's contact number is listed on this page for reference. Pharmacies usually handle these calls.

This is general information based on national, manufacturer-reported FDA data. It may not match your local pharmacy's stock, and it is not personal medical advice.

Quick checklist for the pharmacy counter

  • Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
  • If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.

Where Else Can I Get Hydrocortisone Acetate?

From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage and other dosage forms.

  • Some listings are repackagers, which relabel another company’s product.
  • A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same Medicine From Other Companies (Not Reporting a Shortage)

The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.

ProductStrengthForm / routeCompanyNDC
Hydrocortisone Acetate 30 mg Suppository · Rectal Cosette Pharmaceuticals, Inc. 00713-0493-12
Anucort-Hc 25 mg Suppository · Rectal Cosette Pharmaceuticals, Inc. 00713-0503-01
Hydrocortisone Acetate 25 mg Suppository · Rectal Major Pharmaceuticals 00904-7340-12
Hydrocortisone Acetate 25 mg Suppository · Rectal Marlex Pharmaceuticals, Inc. 10135-0751-12
Hemmorex-Hc 25 mg Suppository · Rectal Laser Pharmaceuticals, LLC 16477-0201-12
Hemmorex-Hc 30 mg Suppository · Rectal Laser Pharmaceuticals, LLC 16477-0202-12
Hydrocortisone Acetate 25 mg Suppository · Rectal Rising Pharma Holdings, Inc. 16571-0676-21
Hydrocortisone Acetate 25 mg Suppository · Rectal APNAR PHARMA LP 24689-0102-01
Hydrocortisone Acetate 30 mg Suppository · Rectal APNAR PHARMA LP 24689-0103-01
Hydrocortisone Acetate 25 mg Suppository · Rectal Patrin Pharma Inc. 39328-0029-12
Hydrocortisone Acetate 30 mg Suppository · Rectal Patrin Pharma Inc. 39328-0129-12
Hydrocortisone Acetate 25 mg Suppository · Rectal A-S Medication Solutions 50090-6331-00
Hydrocortisone Acetate 25 mg Suppository · Rectal AvPAK 50268-0411-01
Hydrocortisone Acetate 25 mg Suppository · Rectal Golden State Medical Supply, Inc. 51407-0665-12
Hydrocortisone Acetate 25 mg Suppository · Rectal Bryant Ranch Prepack 63629-2530-01
Hydrocortisone Acetate 30 mg Suppository · Rectal Bryant Ranch Prepack 63629-2531-01
Anusol Hc 25 mg Suppository · Rectal Salix Pharmaceuticals, Inc 65649-0411-12
Proctocort 30 mg Suppository · Rectal Salix Pharmaceuticals, Inc 65649-0511-12
Hydrocortisone Acetate 25 mg Suppository · Rectal Westminster Pharmaceuticals, LLC 69367-0243-12
Hydrocortisone Acetate 30 mg Suppository · Rectal Westminster Pharmaceuticals, LLC 69367-0260-12
Hydrocortisone Acetate 25 mg Suppository · Rectal Proficient Rx LP 71205-0976-12
Hydrocortisone Acetate 25 mg Suppository · Rectal Nivagen Pharmaceuticals, Inc. 75834-0147-12
Hydrocortisone Acetate 25 mg Suppository · Rectal AARNA USA INC. 82568-0150-01
Hydrocortisone Acetate 30 mg Suppository · Rectal AARNA USA INC. 82568-0160-01

Therapeutic Equivalents and Pricing 30 products

Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.

ProductManufacturerPackagePharmacy cost per unit (NADAC)FDA rated equivalentAvailability
Hydrocortisone Acetate 25 mgNDC 24689-0102-01 APNAR 12 suppositories $1.101 — FDA listed
Hydrocortisone Acetate 25 mgNDC 00904-7340-12 Major 12 suppositories $1.114 — FDA listed
Hydrocortisone Acetate 25 mgNDC 16571-0676-21 Rising 12 suppositories $1.114 — FDA listed
Hydrocortisone Acetate 30 mgNDC 00574-7093-12 Padagis 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 00713-0493-12 Cosette 12 suppositories — — FDA listed
Hemmorex-HC 30 mgNDC 16477-0202-12 Laser 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 16571-0164-21 Rising 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 24689-0103-01 APNAR 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 39328-0129-12 Patrin 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 63629-2531-01 Bryant 12 suppositories — — FDA listed
Proctocort 30 mgNDC 65649-0511-12 Salix 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 69367-0260-12 Westminster 12 suppositories — — FDA listed
Hydrocortisone Acetate 30 mgNDC 82568-0160-01 AARNA 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 00574-7090-12 Padagis 12 suppositories — — FDA listed
Anucort-Hc 25 mgNDC 00713-0503-01 Cosette 100 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 10135-0751-12 Marlex 12 suppositories — — FDA listed
Hemmorex-HC 25 mgNDC 16477-0201-12 Laser 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 39328-0029-12 Patrin 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 50090-6331-00 A-S 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 50268-0411-01 AvPAK 100 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 51407-0665-12 Golden 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 63629-2530-01 Bryant 12 suppositories — — FDA listed
Anusol HC 25 mgNDC 65649-0411-12 Salix 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 68071-2259-02 NuCare 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 69367-0243-12 Westminster 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 70752-0169-02 QUAGEN 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 71205-0976-12 Proficient 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 75834-0147-12 Nivagen 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 82568-0150-01 AARNA 12 suppositories — — FDA listed
Hydrocortisone Acetate 25 mgNDC 68788-4190-01 Preferred 12 suppositories — — FDA listed

These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.

Codes & Classification for pharmacists and billers

GCN Seq No
031773
GCN
27944
HICL code
002863
Ingredient (HICL)
Hydrocortisone Acetate
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q3
Therapeutic class — intermediate (HIC2)
Anal-Rectal Preparations
HIC3 code
Q3A
Therapeutic class — specific (HIC3)
Rectal Preparations
AHFS code
84:06.08.00
AHFS class
Corticosteroids (Skin, Mucous Membrane)
FDB label name
HYDROCORTISONE AC 30 MG SUPP
FDB brand name
Hydrocortisone Acetate
Legend status
F — Federal legend — prescription drug or device
GPI-14
89100010105237
GPI class
Hydrocortisone Acetate

Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Hydrocortisone acetate Shortage FAQs

Is hydrocortisone acetate discontinued?

Only Padagis US’s version. Padagis US has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 22, 2026), while 16 other companies still sell the same medicine and have not reported a problem (Cosette Pharmaceuticals, Major Pharmaceuticals, Marlex Pharmaceuticals and 13 more). It is not a nationwide shortage.

Which strengths of hydrocortisone acetate are affected?

The FDA record covers 2 strengths: 25 mg, 30 mg. Every strength on the record is still made by at least one company, though stock varies by pharmacy.

Which hydrocortisone acetate products are affected?

Hydrocortisone Acetate Suppository, 30 mg (NDC 00574-7093-12); Hydrocortisone Acetate Suppository, 25 mg (NDC 00574-7090-12). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.

When will hydrocortisone acetate be available again?

A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Cosette Pharmaceuticals, Major Pharmaceuticals, Marlex Pharmaceuticals and 13 more, so ask your pharmacy to order another company’s version.

Can I still get hydrocortisone acetate somewhere?

Other companies (Cosette Pharmaceuticals, Major Pharmaceuticals, Marlex Pharmaceuticals and 13 more) sell the same medicine and have not reported a problem. 9 other dosage forms of hydrocortisone acetate are also listed. See “Where else can I get hydrocortisone acetate?” above — stock still varies by pharmacy.

What should I do if I take hydrocortisone acetate?

Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.

How to Read the Supply-Risk Rating

Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.

  • Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Hydrocortisone acetate is rated Low: 0 of 5 risk factors.
  • Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
  • High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.

Back to this drug’s rating ↑ · How we rate supply risk, in full

Where This Data Comes From

For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.

Back to all current drug shortages